- Home
- CRMT vs PRQR Comparison
CRMT vs PRQR Comparison
Compare CRMT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMT
- PRQR
- Stock Information
- Founded
- CRMT 1981
- PRQR 2012
- Country
- CRMT United States
- PRQR Netherlands
- Employees
- CRMT N/A
- PRQR N/A
- Industry
- CRMT Other Specialty Stores
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- CRMT Consumer Discretionary
- PRQR Health Care
- Exchange
- CRMT Nasdaq
- PRQR Nasdaq
- Market Cap
- CRMT 284.5M
- PRQR 232.8M
- IPO Year
- CRMT N/A
- PRQR 2014
- Fundamental
- Price
- CRMT $33.69
- PRQR $1.99
- Analyst Decision
- CRMT Buy
- PRQR Strong Buy
- Analyst Count
- CRMT 1
- PRQR 8
- Target Price
- CRMT $45.00
- PRQR $8.88
- AVG Volume (30 Days)
- CRMT 186.6K
- PRQR 367.9K
- Earning Date
- CRMT 09-04-2025
- PRQR 11-06-2025
- Dividend Yield
- CRMT N/A
- PRQR N/A
- EPS Growth
- CRMT N/A
- PRQR N/A
- EPS
- CRMT 1.61
- PRQR N/A
- Revenue
- CRMT $1,378,681,000.00
- PRQR $20,129,184.00
- Revenue This Year
- CRMT $6.23
- PRQR N/A
- Revenue Next Year
- CRMT $5.10
- PRQR N/A
- P/E Ratio
- CRMT $20.93
- PRQR N/A
- Revenue Growth
- CRMT 0.64
- PRQR 8.65
- 52 Week Low
- CRMT $32.70
- PRQR $1.07
- 52 Week High
- CRMT $62.72
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- CRMT 27.34
- PRQR 37.71
- Support Level
- CRMT $33.50
- PRQR $2.21
- Resistance Level
- CRMT $37.74
- PRQR $2.50
- Average True Range (ATR)
- CRMT 1.89
- PRQR 0.15
- MACD
- CRMT -0.63
- PRQR -0.04
- Stochastic Oscillator
- CRMT 6.75
- PRQR 13.54
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.